Gary R. Cutter

Q: What Schools Are Affiliated With Gary R. Cutter

Gary R. Cutter is affiliated with the following schools: University of Alabama, University of Missouri, Stanford University, University of Texas Health Science Center at Houston, University of Nevada, Reno, Johns Hopkins University, University of Alabama at Birmingham

Gary R. Cutter's AcademicInfluence.com Rankings

Gary R. Cutter

Mathematics

#4944

World Rank

#6988

Historical Rank

Statistics

#294

World Rank

#355

Historical Rank

Measure Theory

#526

World Rank

#740

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Gary R. Cutter's Degrees

PhD Biostatistics Johns Hopkins University
Bachelors Mathematics Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Math Ranked

Why Is Gary R. Cutter Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gary R. Cutter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Defining the clinical course of multiple sclerosis (2014) (2372)
CARDIA: study design, recruitment, and some characteristics of the examined subjects. (1988) (1450)
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. (1999) (1137)
Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography (2003) (1117)
The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment (1999) (902)
Initial Acquisition of Mutans Streptococci by Infants: Evidence for a Discrete Window of Infectivity (1993) (722)
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. (2006) (649)
Detection of ductal carcinoma in situ in women undergoing screening mammography. (2002) (598)
Influence of computer-aided detection on performance of screening mammography. (2007) (536)
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn (1997) (526)
The prevalence of MS in the United States (2019) (494)
Effect of relapses on development of residual deficit in multiple sclerosis (2003) (413)
Benefit of interferon &bgr;-1a on MSFC progression in secondary progressive MS (2002) (392)
Eight-year follow-up study of brain atrophy in patients with MS (2002) (370)
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review (2015) (370)
Risk of Serious Injury for Young Baseball Pitchers (2011) (360)
Recommendations from the national multiple sclerosis society clinical outcomes assessment task force (1997) (359)
Comparison of full-field digital mammography with screen-film mammography for cancer detection: results of 4,945 paired examinations. (2001) (356)
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis (2010) (332)
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis (2010) (331)
Randomized Trial of Thymectomy in Myasthenia Gravis. (2016) (326)
Natural history of multiple sclerosis symptoms. (2013) (320)
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial (2019) (311)
The Goldman Consensus statement on depression in multiple sclerosis (2005) (309)
Long‐term evolution of multiple sclerosis disability in the treatment era (2016) (308)
Optical coherence tomography: a window into the mechanisms of multiple sclerosis (2008) (302)
Optical coherence tomography and disease subtype in multiple sclerosis (2007) (295)
Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. (1990) (281)
Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer. (2002) (274)
A study of the reliability and comparative validity of the cardia dietary history. (1994) (274)
Dietary therapy slows the return of hypertension after stopping prolonged medication. (1985) (273)
Infectious causes of multiple sclerosis (2006) (269)
Early inhaled nitric oxide therapy in premature newborns with respiratory failure. (2006) (266)
The effectiveness of smoking cessation methods for smokers in public health maternity clinics: a randomized trial. (1985) (265)
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview (2015) (265)
Randomized trial of thymectomy in myasthenia gravis. (2016) (263)
Cardiovascular risk factors in young adults. The CARDIA baseline monograph. (1991) (260)
Factors that influence adherence with disease-modifying therapy in MS (2009) (257)
Interactions between cannabidiol and commonly used antiepileptic drugs (2017) (250)
Validity of self-reported colorectal cancer screening behavior. (2000) (247)
Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study. (1987) (244)
Persistent pain and uncomfortable sensations in persons with multiple sclerosis (2007) (242)
A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. (1989) (239)
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis (2007) (234)
Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population. (1990) (232)
Accuracy of screening mammography interpretation by characteristics of radiologists. (2004) (220)
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta‐analytic approach (2009) (217)
Comorbidity delays diagnosis and increases disability at diagnosis in MS (2009) (215)
Strategies for the Prevention of Early‐Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis (1994) (212)
The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials (2002) (209)
Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update (2006) (202)
Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. (1985) (196)
Survival in MS (2012) (196)
Comorbidity, socioeconomic status and multiple sclerosis (2008) (187)
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated (2009) (186)
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. (2009) (185)
Performance of Screening Mammography among Women with and without a First-Degree Relative with Breast Cancer (2000) (185)
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis (2021) (185)
Performance of diagnostic mammography for women with signs or symptoms of breast cancer. (2002) (183)
The Effect of Cigarette Smoking on Neonatal Anthropometric Measurements (1995) (175)
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite (2003) (173)
Mortality in patients with multiple sclerosis (2013) (173)
Intrauterine Growth Retardation: Standards for Diagnosis (1989) (172)
Smoking, maternal age, fetal growth, and gestational age at delivery. (1990) (172)
Clinical outcomes assessment in multiple sclerosis (1996) (172)
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. (2001) (170)
Randomized study combining interferon and glatiramer acetate in multiple sclerosis (2013) (170)
Prevalence odds ratio versus prevalence ratio: choice comes with consequences (2016) (169)
Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise (2020) (169)
A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis (2013) (167)
Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. (2005) (165)
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis (2005) (161)
Alcohol intake and blood pressure in young adults: the CARDIA Study. (1990) (160)
Low-dose aspirin therapy to prevent preeclampsia. (1993) (159)
Cigarette smoking behavior is strongly related to educational status: the CARDIA study. (1990) (154)
Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. (2000) (151)
Does multiple sclerosis–associated disability differ between races? (2006) (148)
New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis (2000) (147)
Physician predictors of mammographic accuracy. (2005) (147)
Less is more, or almost as much: A 15‐item quality‐of‐life instrument for myasthenia gravis (2008) (146)
The Relationship Between Maternal Hematocrit and Pregnancy Outcome (1991) (146)
Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. (2009) (141)
Defining reliable disability outcomes in multiple sclerosis. (2015) (140)
A randomized controlled study of the acute and chronic effects of cooling therapy for MS (2003) (139)
Intrarater and interrater reliability of the MS functional composite outcome measure (2000) (139)
Inhaled Nitric Oxide in Preterm Infants: An Individual-Patient Data Meta-analysis of Randomized Trials (2011) (136)
BED REST IN PREGNANCY (1994) (135)
Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenation (2011) (135)
Psychological correlates of weight fluctuation. (1995) (134)
Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping With Death or Severe Intraventricular Hemorrhage Among Preterm Infants. (2019) (134)
High frequency of adverse health behaviors in multiple sclerosis (2009) (133)
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. (2000) (130)
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. (2003) (130)
Effect of breast augmentation on the accuracy of mammography and cancer characteristics. (2004) (130)
Cell-based therapeutic strategies for multiple sclerosis (2017) (128)
Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS (2001) (128)
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis (2015) (127)
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. (2008) (127)
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis (2015) (126)
Preferred Sources of Health Information in Persons With Multiple Sclerosis: Degree of Trust and Information Sought (2013) (125)
Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity (2009) (124)
Evaluation of health promotion and education programs. (1984) (122)
The prospective relationships between smoking and weight in a young, biracial cohort: the Coronary Artery Risk Development in Young Adults Study. (1998) (119)
Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care. (2005) (118)
Disability in multiple sclerosis (2013) (117)
Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis (2011) (116)
Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. (1992) (114)
Extended interval dosing of natalizumab in multiple sclerosis (2016) (114)
Plasmid-containing strains of Streptococcus mutans cluster within family and racial cohorts: implications for natural transmission (1988) (113)
Issues in the natural history and treatment of coronary heart disease in black populations: surgical treatment. (1984) (112)
Validation of the NARCOMS registry: diagnosis (2007) (111)
Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach. (2011) (110)
Competing demands in the office visit: what influences mammography recommendations? (2001) (108)
Diet quality is associated with disability and symptom severity in multiple sclerosis (2018) (108)
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis (2015) (107)
A positive association between maternal serum zinc concentration and birth weight. (1990) (106)
Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. (2006) (105)
Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease (2012) (104)
Symptom-limited graded treadmill exercise testing in young adults in the CARDIA study. (1992) (103)
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial (2019) (102)
Construction of an efficient evaluative instrument for Myasthenia Gravis: The MG composite (2008) (102)
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial (2019) (102)
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing (2019) (101)
Recommendations for myasthenia gravis clinical trials (2012) (101)
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis (2010) (101)
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study (2018) (100)
Mammography Facility Characteristics Associated With Interpretive Accuracy of Screening Mammography (2008) (98)
Assessing changes in relapse rates in multiple sclerosis (2010) (97)
The association between obesity and screening mammography accuracy. (2004) (96)
Training and certification of blood pressure observers. (1983) (96)
Association between mammography timing and measures of screening performance in the United States. (2005) (96)
A practical randomized trial to improve diabetes care (2004) (94)
The Relationships Among Psychosocial Profile, Maternal Size, and Smoking in Predicting Fetal Growth Retardation (1992) (94)
Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants. (2016) (91)
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses. (2017) (91)
Testing the risk compensation hypothesis for safety helmets in alpine skiing and snowboarding (2007) (90)
Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography. (2005) (90)
Mammography screening and differences in stage of disease by race/ethnicity. (2002) (90)
Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. (2016) (88)
Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study. (2019) (88)
Prematurity, postdates, and growth retardation: the influence of use of ultrasonography on reported gestational age. (1989) (87)
Diagnoses, symptoms, and attribution of symptoms among black and white inpatients admitted for coronary heart disease. (1994) (87)
No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis (2014) (86)
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. (2006) (86)
Promoting physical activity in low-income African-American communities: the PARR project. (1993) (85)
Influence of genetic background on tumor karyotypes: Evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma (2009) (84)
Randomized Trial Testing a Worksite Sun Protection Program in an Outdoor Recreation Industry (2005) (83)
Comparative analysis of therapeutic options used for myasthenia gravis (2010) (83)
Reproducibility of optical coherence tomography in multiple sclerosis. (2008) (82)
Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis (2008) (81)
Randomized Trials on Consider This, a Tailored, Internet-Delivered Smoking Prevention Program for Adolescents (2008) (81)
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. (2015) (81)
Changes in the ascertainment of multiple sclerosis (2005) (80)
Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis? (2014) (77)
A systematic review of the incidence and prevalence of cancer in multiple sclerosis (2015) (77)
Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS (2010) (76)
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma (2010) (75)
Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic setting. (2001) (75)
Disparities in the management of multiple sclerosis–related bladder symptoms (2007) (73)
Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings (2008) (73)
The Relationship Between Maternal and Neonatal Anthropometric Measurements in Term Newborns (1995) (73)
Performance comparison of full-field digital mammography to screen-film mammography in clinical practice. (2002) (73)
Natalizumab-associated PML (2017) (73)
Cumulative impact of comorbidity on quality of life in MS (2012) (72)
Relation of vision to global and regional brain MRI in multiple sclerosis (2007) (72)
Status of the Thymectomy Trial for Nonthymomatous Myasthenia Gravis Patients Receiving Prednisone (2008) (72)
Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1 (2016) (71)
Factors that predict Health-Related Q uality of Life in patients with relapsing -remitting multiple sclerosis (2003) (71)
Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts data (2009) (69)
Association between comorbidity and clinical characteristics of MS (2011) (69)
The Multiple Sclerosis Intimacy and Sexuality Questionnaire — re-validation and development of a 15-item version with a large US sample (2013) (68)
The risk of renal calculi in spinal cord injury patients. (1984) (68)
Serum Folate and Fetal Growth Retardation: A Matter of Compliance? (1992) (68)
Accuracy of Blood Pressure Measurement Devices in Pregnancy: A Systematic Review of Validation Studies (2018) (67)
Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study☆ (2012) (67)
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS (2011) (66)
MRI as a marker for disease heterogeneity in multiple sclerosis (2005) (66)
Validation of the NARCOMS Registry: fatigue assessment (2005) (65)
Evaluating the value of low-vision services. (1997) (64)
Differences in the detection and enumeration of mutans streptococci due to differences in methods. (1995) (64)
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients (2000) (63)
Fetal biparietal diameter, head circumference, abdominal circumference and femur length. A comparison by race and sex. (1993) (63)
Physical Activity and Self-Reported Cardiovascular Comorbidities in Persons with Multiple Sclerosis: Evidence from a Cross-Sectional Analysis (2011) (63)
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-up. (2010) (62)
A cost-effectiveness analysis of self-help smoking cessation methods for pregnant women. (1988) (62)
Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm delivery. (1990) (62)
International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r (2016) (62)
Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients (2005) (61)
A classification system to evaluate weight maintainers, gainers, and losers. (1997) (61)
Treatment for Mild Chronic Hypertension during Pregnancy. (2022) (61)
Divergent effects of AKI to CKD models on inflammation and fibrosis. (2018) (60)
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) (2020) (60)
Effect of conventional dental restorative treatment on bacteria in saliva. (1992) (60)
Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry. (2015) (60)
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) (2020) (60)
Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates. (1993) (59)
Effects of the Sunny Days, Healthy Ways curriculum on students in grades 6 to 8. (2006) (59)
Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease. (2012) (59)
Mortality in neuromyelitis optica is strongly associated with African ancestry (2018) (59)
Placebo-controlled study in neuromyelitis optica—Ethical and design considerations (2015) (57)
Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25) (2000) (56)
Randomized Trial on the 5 a Day, the Rio Grande Way Website, A Web-based Program to Improve Fruit and Vegetable Consumption in Rural Communities (2008) (56)
Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? (2005) (56)
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional C omposite (2004) (55)
Effect of Emailed Messages on Return Use of a Nutrition Education Website and Subsequent Changes in Dietary Behavior (2007) (54)
Transmission of mutans streptococci to infants following short term application of an iodine-NaF solution to mothers' dentition. (1993) (53)
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis (2020) (53)
Maternal risk factors and their influence on fetal anthropometric measurements. (1993) (52)
Hypothermia as a risk factor for pediatric cardiothoracic surgical site infection. (2001) (50)
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. (2019) (50)
A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites. (1999) (49)
Randomized Trial of Thymectomy in Myasthenia Gravis. (2017) (49)
Enhancing antimelanoma immune responses through apoptosis (2003) (49)
Cognition in patients with newly diagnosed brain metastasis: profiles and implications (2014) (48)
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence? (2014) (47)
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses (2008) (47)
Employment and absenteeism in working-age persons with multiple sclerosis (2017) (46)
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability (2017) (46)
A cross-sectional study of bone health in multiple sclerosis (2009) (46)
Inactivation of the p16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin's T-Cell Lymphoma (2007) (46)
Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. (2014) (45)
Which symptoms contribute the most to patients’ perception of health in multiple sclerosis? (2017) (45)
The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. (1995) (45)
The clinical presentation, prevalence, and risk factors of focal corneal infiltrates in soft contact lens wearers. (1996) (45)
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (2012) (44)
Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S. (2014) (44)
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab (2013) (44)
Optimization of technique factors for a silicon diode array full-field digital mammography system and comparison to screen-film mammography with matched average glandular dose. (2003) (44)
Correlates of attendance and compliance in the hypertension detection and follow-up program. (1982) (44)
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review (2015) (44)
Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging Selection (2020) (44)
Characteristics of Streptococcus mutans genotypes and dental caries in children. (2013) (43)
Low birth weight, intrauterine growth retardation, and preterm delivery. (1985) (43)
The risk of bladder calculi in patients with spinal cord injuries. (1985) (43)
Increasing sun protection in winter outdoor recreation a theory-based health communication program. (2008) (43)
LOW‐DOSE ASPIRIN: LACK OF ASSOCIATION WITH AN INCREASE IN ABRUPTIO PLACENTAE OR PERINATAL MORTALITY (1995) (43)
Factors associated with early childhood caries incidence among high caries-risk children. (2015) (43)
Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areas. (2012) (43)
Impact of multiple sclerosis relapse: The NARCOMS participant perspective. (2015) (43)
Treatment trials in progressive MS—current challenges and future directions (2013) (42)
Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. (2014) (42)
Black-White Differences in Newborn Anthropometric Measurements (1991) (42)
Impact of Hypertension Information on High Blood Pressure Control Between 1973 and 1978 (1980) (42)
Declining Financial Capacity in Mild Cognitive Impairment: A Six-Year Longitudinal Study (2019) (41)
Impact of maternal group B streptococcal screening on pediatric management in full-term newborns. (1996) (41)
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis (2010) (41)
The relationship between maternal hematocrit and pregnancy outcome: black-white differences. (1993) (40)
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials (2010) (40)
Preliminary Results From The Collaborative Alabama And Scandinavian Study Of Successive Small‐For‐Gestational Age Births: Report From a Symposium In Trondheim 9th June 1988 (1989) (40)
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial (2020) (40)
Reality check: perceived versus actual performance of community mammographers. (2006) (40)
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution (2011) (40)
Weight changes associated with unilateral STN DBS and advanced PD. (2009) (40)
Use of eHealth and mHealth technology by persons with multiple sclerosis. (2019) (40)
A survey of dietary characteristics in a large population of people with multiple sclerosis. (2018) (40)
Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey (2015) (39)
The relationship between maternal serum zinc levels during pregnancy and birthweight. (1991) (39)
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease (2020) (39)
Real-time quantitative polymerase chain reaction for enumeration of Streptococcus mutans from oral samples. (2011) (39)
Current realities of delivering mammography services in the community: do challenges with staffing and scheduling exist? (2005) (39)
Cross‐sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment (2019) (39)
Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma (2007) (39)
Health Literacy Association With Health Behaviors and Health Care Utilization in Multiple Sclerosis: A Cross-Sectional Study (2014) (38)
Validation of the NARCOMS Registry: pain assessment (2005) (38)
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease (2014) (38)
Physical activity of public housing residents in Birmingham, Alabama. (1993) (38)
The Risk of Bladder Calculi in Patients With Spinal Cord Injuries (1985) (38)
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis (2011) (37)
Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial. (1995) (37)
Modelling new enhancing MRI lesion counts in multiple sclerosis (2001) (37)
Clinical characteristics of progressive relapsing multiple sclerosis (2004) (36)
Genetic Diversity of Plaque Mutans Streptococci with rep-PCR (2011) (36)
Increasing age at disability milestones among MS patients in the MSBase Registry (2012) (36)
Prevalence and diffusion of helmet use at ski areas in Western North America in 2001–02 (2004) (36)
Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS). (1997) (36)
Relapses in multiple sclerosis: Relationship to disability. (2016) (36)
Composite MRI scores improve correlation with EDSS in multiple sclerosis (2010) (35)
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics. (2012) (35)
Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns. (2014) (35)
Constraint-induced movement therapy for the lower extremities in multiple sclerosis: case series with 4-year follow-up. (2013) (35)
Implementing clinical trials on an international platform: Challenges and perspectives (2012) (35)
The cancer information service research consortium: an emerging laboratory for cancer control research. (1998) (34)
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States (2014) (34)
Oral leukoplakia and adolescent smokeless tobacco use. (1991) (34)
Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study (2019) (33)
Environmental cues to UV radiation and personal sun protection in outdoor winter recreation. (2010) (33)
The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial (2008) (33)
“Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry (2013) (32)
Causes of death among persons with multiple sclerosis. (2015) (32)
Mediation of a middle school skin cancer prevention program. (2006) (32)
Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis (1995) (32)
Evolution of clinical trials in multiple sclerosis (2019) (32)
Trigeminal Neuralgia Commonly Precedes the Diagnosis of Multiple Sclerosis. (2017) (32)
Randomized Trial on Sun Safety Education at Ski and Snowboard Schools in Western North America (2007) (31)
Elevated levels of midtrimester maternal serum α-fetoprotein are associated with preterm delivery but not with fetal growth retardation (1992) (31)
Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns. (1994) (31)
Ethics of placebo-controlled clinical trials in multiple sclerosis (2008) (31)
Differences in Alzheimer disease clinical trial outcomes based on age of the participants (2015) (31)
Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension. (1984) (31)
Radiologist Uncertainty and the Interpretation of Screening (2004) (30)
Practice Patterns of Family Physicians in Practice-Based Research Networks: A Report From ASPN (1999) (30)
National estimates of self-reported sitting time in adults with multiple sclerosis (2018) (30)
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas (2021) (30)
Predictors of radiologists' perceived risk of malpractice lawsuits in breast imaging. (2009) (30)
Clinical and Economic Effects of iNO in Premature Newborns With Respiratory Failure at 1 Year (2009) (30)
Smoking Status over Two Years in Patients with Multiple Sclerosis (2008) (29)
Smokers with Multiple Sclerosis Are More Likely to Report Comorbid Autoimmune Diseases (2011) (29)
Cervical examination and tocodynamometry at 28 weeks' gestation: prediction of spontaneous preterm birth. (1995) (29)
Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the Hypertension Detection and Follow-up Program cooperative group. (1982) (29)
Low‐dose aspirin therapy to prevent preeclampsia (1994) (29)
Testing the Long‐Term Effects of the Go Sun Smart Worksite Health Communication Campaign: A Group‐Randomized Experimental Study (2008) (29)
Inhaled Nitric Oxide in preterm infants: a systematic review and individual patient data meta-analysis (2010) (29)
Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program (2019) (28)
Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival of Dogs With Spontaneous Bone Cancer. (2011) (28)
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial (2021) (28)
Fetal Deaths in Alabama, 1974–1983: A Birth Weight‐Specific Analysis (1987) (28)
A Phase II Study of Continuous Oral mTOR Inhibitor Everolimus for Recurrent, Radiographic-Progressive Neurofibromatosis Type 1-Associated Pediatric Low-Grade Glioma: A Neurofibromatosis Clinical Trials Consortium Study. (2020) (28)
Risk factors and the natural history of coronary heart disease in blacks. (1991) (28)
Pathogenic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat. (1998) (27)
Intensive care unit readmission during childhood after preterm birth with respiratory failure. (2014) (27)
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS. (2014) (27)
Prevalence and incidence of early childhood caries among African-American children in Alabama. (2015) (27)
The prevalence and predictors of helmet use by skiers and snowboarders at ski areas in western North America in 2001. (2003) (27)
Variability of interpretive accuracy among diagnostic mammography facilities. (2009) (27)
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis (2010) (27)
The Pediatric Costs of Strategies for Minimizing the Risk of Early‐Onset Group B Streptococcal Disease (1997) (27)
Effect of breast augmentation on the accuracy of mammography and cancer characteristics (2004) (27)
The Influence of Previous Low Birth Weight on Birth Weight, Gestational Age, and Anthropometric Measurements in the Current Pregnancy (1992) (26)
Substantial burden of dizziness in multiple sclerosis. (2013) (26)
A new way to estimate neurologic disease prevalence in the United States (2019) (26)
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States. (2012) (26)
Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change? (2015) (26)
Care Partners and Multiple Sclerosis: Differential Effect on Men and Women. (2015) (26)
Video Telehealth Pulmonary Rehabilitation Intervention In COPD Reduces 30-day Readmissions. (2019) (26)
Fertility Restoration of Maize CMS-C Altered by a Single Amino Acid Substitution within the Rf4 bHLH Transcription Factor. (2019) (26)
Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry (2018) (26)
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx) (2020) (25)
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants (2017) (25)
Retinal architecture predicts pupillary reflex metrics in MS (2009) (25)
Who Are the Weight Maintainors (1995) (25)
A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma. (2011) (25)
Composite end points to assess delay of disability progression by MS treatments (2014) (25)
Impact of customized videotape education on quality of life in patients with chronic obstructive pulmonary disease. (2006) (25)
Community-based mammography practice: services, charges, and interpretation methods. (2005) (24)
Pubertal development in Rett syndrome deviates from typical females. (2014) (24)
Maternal serum alpha 2-macroglobulin and fetal growth retardation. (1991) (24)
Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study (2006) (24)
Rose Questionnaire responses among black and white inpatients admitted for coronary heart disease: findings from the Birmingham-BHS Project. (1993) (24)
Association Between Early Childhood Caries and Colonization with Streptococcus mutans Genotypes From Mothers. (2017) (24)
Biomarker development for myasthenia gravis (2012) (24)
A Research Model for Investigating the Effects of Artificial Food Colorings on Children With ADHD (2011) (23)
Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure. (2014) (23)
Is Bayesian Analysis Ready for Use in Phase III Randomized Clinical Trials?: Beware the Sound of the Sirens (2005) (23)
Health insurance affects the use of disease-modifying therapy in multiple sclerosis (2016) (23)
Regional Gray Matter Atrophy in Relapsing Remitting Multiple Sclerosis: Baseline Analysis of Multi-Center Data (2015) (23)
Risk tolerance to MS therapies: Survey results from the NARCOMS registry. (2015) (23)
Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium (2011) (23)
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation (2013) (23)
Enhancing Industry-Based Dissemination of an Occupational Sun Protection Program with Theory-Based Strategies Employing Personal Contact (2012) (23)
High hypothetical interest in physician-assisted death in multiple sclerosis (2017) (23)
Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis (2020) (23)
Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life (2019) (23)
Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis. (2018) (22)
A Framework of Care in Multiple Sclerosis, Part 2: Symptomatic Care and Beyond. (2017) (22)
The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments. (2019) (22)
The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease (2017) (22)
Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia (2017) (22)
Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology (2017) (22)
Some Examples for Teaching Regression Toward the Mean from a Sampling Viewpoint (1976) (22)
Long-term cost-effectiveness model of interferon beta-1b in the early treatment of multiple sclerosis in the United States. (2012) (22)
Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis. (2017) (22)
Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population (2013) (22)
Early complement genes are associated with visual system degeneration in multiple sclerosis. (2019) (22)
Capacity of patients with brain metastases to make treatment decisions (2015) (21)
Effects of Program Exposure and Engagement With Tailored Prevention Communication on Sun Protection by Young Adolescents (2008) (21)
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets (2019) (21)
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b (2019) (21)
Futility studies (2006) (21)
Sensitivity, specificity and predictive value of saliva thiocyanate among pregnant women. (1989) (21)
Natalizumab Extended Interval Dosing Is Associated with a Reduction in Progressive Multifocal Leukoencephalopathy (PML) Risk in the Touch® Registry (2018) (21)
Factors Associated with Discontinuation of Continuous Subcutaneous Insulin Infusion (1988) (21)
Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials. (1999) (21)
Personalized medicine: The return of the house call? (2012) (21)
Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder (2019) (21)
Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive Impairment (2017) (20)
Relationships of low density lipoprotein cholesterol with age and other factors: a cross-sectional analysis of the CARDIA study. (1988) (20)
Validation of NARCOMS Depression Scale (2008) (20)
Motivating public school districts to adopt sun protection policies: a randomized controlled trial. (2011) (20)
Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov (2015) (20)
High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex (2018) (20)
Gender differences in prednisone adverse effects (2018) (19)
EDSS variability before randomization may limit treatment discovery in primary progressive MS (2013) (19)
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1 (2019) (19)
Psychometric evaluation of the myasthenia gravis composite using rasch analysis (2012) (19)
Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function (2018) (19)
Comorbidity is associated with disease activity in MS (2020) (19)
Rationale, design, samples, and baseline sun protection in a randomized trial on a skin cancer prevention intervention in resort environments. (2016) (19)
Phase-III, randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis: Project BIPAMS. (2018) (19)
Mammographers’ Perception of Women’s Breast Cancer Risk (2005) (19)
Variability of Two Plaque Sampling Methods in Quantitation of Streptococcus mutans (2010) (18)
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial (2016) (18)
Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex. (2020) (18)
Portable tonometers: a clinical comparison of applanation and indentation devices. (1989) (18)
Understanding and Preventing Loss to Follow-up: Experiences From the Spinal Cord Injury Model Systems. (2018) (18)
Validation of a risk function to predict mortality in a VA population with coronary artery disease. (1982) (18)
Practice parameters and focusing research: Plasma exchange for myasthenia gravis (2011) (18)
Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials (2018) (18)
Testing a Theory-Based Health Communication Program: A Replication of Go Sun Smart in Outdoor Winter Recreation (2009) (18)
DDT contamination of a North Alabama aquatic ecosystem (1986) (18)
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy (2020) (18)
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis (2016) (17)
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis (2012) (17)
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial (2021) (17)
Improvement in mammography quality control: 1987-1995. (1998) (17)
Characteristics of Severe Hypoglycemia in the Patient With Insulin-Dependent Diabetes (1994) (17)
Relative efficiency and sample size for cluster randomized trials with variable cluster sizes (2011) (17)
Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple Sclerosis. (2019) (17)
Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study (2018) (17)
Gender differences in quality of life among patients with myasthenia gravis in China (2020) (17)
Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors. (2010) (17)
How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity (2021) (17)
Challenging Assumptions About African American Participation in Alzheimer Disease Trials. (2017) (17)
Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS (2016) (17)
NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (2018) (16)
Maternal Psychological Characteristics and Intrauterine Growth Retardation (1991) (16)
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry (2014) (16)
Effects of Subthalamic Nucleus Deep Brain Stimulation on Objective Sleep Outcomes in Parkinson's Disease (2017) (16)
VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts. (2015) (16)
Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy (2021) (16)
Cortical Activation Elicited by Subthalamic Deep Brain Stimulation Predicts Postoperative Motor Side Effects (2019) (16)
Evolution of MS lesions to black holes under DNA vaccine treatment (2012) (16)
Treatment with interferon beta for multiple sclerosis. (2012) (16)
Chronic Cerebrospinal Vascular Insufficiency Is Not Associated with HLA DRB1*1501 Status in Multiple Sclerosis Patients (2011) (15)
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items (2014) (15)
Randomized trial evaluating computer-based sun safety education for children in elementary school (2008) (15)
Effect of an intervention on observed sun protection by vacationers in a randomized controlled trial at North American resorts. (2017) (15)
Methodological issues in weight cycling (1996) (15)
Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis (2020) (15)
The promise of futility trials in neurological diseases (2015) (15)
Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial (2021) (15)
An introduction to Mendelian randomization with applications in neurology. (2018) (15)
Sun Safe Workplaces: Effect of an Occupational Skin Cancer Prevention Program on Employee Sun Safety Practices (2018) (15)
Continuous Electroencephalography (cEEG) Monitoring and Outcomes of Critically Ill Patients (2017) (15)
Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PD (2011) (14)
Neonatal mortality in infants born weighing 501 to 1000 grams. The influence of changes in birth weight distribution and birth weight-specific mortality rates on neonatal survival. (1985) (14)
The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: results of a cross-sectional study in patients from the Hypertension Detection and Follow-up Program. (1990) (14)
Assessing Accuracy of Mammography in the Presence of Verification Bias and Intrareader Correlation (2005) (14)
Application of survival analysis techniques to evaluation of factors affecting compliance in a clinical trial of hypertension control (1980) (14)
Who are the weight maintainers? (1995) (14)
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years. (2017) (14)
Naturally occurring translational models for development of cancer gene therapy (2006) (14)
Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center. (2016) (13)
Effect of in‐painting on cortical thickness measurements in multiple sclerosis: A large cohort study (2015) (13)
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes. (2019) (13)
Fetal Growth in Women Using Low-Dose Aspirin for the Prevention of Preeclampsia: Effect of Maternal Size (1995) (13)
Comparative utility of disability progression measures in PPMS (2017) (13)
Dissemination of Go Sun Smart in Outdoor Recreation: Effect of Program Exposure on Sun Protection of Guests at High-Altitude Ski Areas (2014) (13)
Impact of patient history on residents' evaluation on child sexual abuse. (1995) (13)
Expanding occupational sun safety to an outdoor recreation industry: a translational study of the Go Sun Smart program (2012) (13)
Usefulness of various maternal skinfold measurements for predicting newborn birth weight. (1992) (12)
Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis (2011) (12)
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG‐CE) (2021) (12)
Statistical issues in neutralizing antibodies (2003) (12)
Sustainability of the Dissemination of an Occupational Sun Protection Program in a Randomized Trial (2012) (12)
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials (2020) (12)
A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry (2018) (12)
The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics. (2012) (12)
Potentially Modifiable Factors Associated With Physical Activity in Individuals With Multiple Sclerosis (2017) (12)
Examining the Impact of Refractory Myasthenia Gravis on Healthcare Resource Utilization in the United States: Analysis of a Myasthenia Gravis Foundation of America Patient Registry Sample (2019) (12)
Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study (2020) (12)
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial (2021) (12)
Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer. (2011) (12)
DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial (2018) (12)
Tuberous Sclerosis Complex Genotypes and Developmental Phenotype. (2019) (11)
Blood Pressure, Growth Retardation, and Preterm Delivery (1992) (11)
Hydroxychloroquine for Primary Progressive Multiple Sclerosis (2021) (11)
The timed 25-foot walk in a large cohort of multiple sclerosis patients (2021) (11)
Assessment of Caregiver Inventory for Rett Syndrome (2017) (11)
Results of a Randomized Trial on an Intervention Promoting Adoption of Occupational Sun Protection Policies (2018) (11)
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis. (2022) (11)
Perceptions of risk and adherence to care in MS patients during the COVID-19 pandemic: A cross-sectional study (2021) (11)
Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation services. (2014) (11)
Minimal manifestation status and prednisone withdrawal in the MGTX trial (2020) (11)
Hand stereotypies (2019) (11)
A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy Controls (2014) (11)
Prediction of response to sodium intervention for blood pressure control. (1986) (11)
Mutans streptococci enumeration and genotype selection using different bacitracin-containing media. (2014) (11)
Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: results of a matching-adjusted indirect comparison. (2017) (10)
NARCOMS and Other Registries in Multiple Sclerosis (2021) (10)
Implementation of Occupational Sun Safety at a 2-Year Follow-Up in a Randomized Trial: Comparison of Sun Safe Workplaces Policy Intervention to Attention Control (2018) (10)
Biomarker positive and negative subjects in the ADNI cohort: clinical characterization. (2012) (10)
Pooling Morphometric Estimates: A Statistical Equivalence Approach (2016) (10)
Learning from the past: reflections on recently completed myasthenia gravis trials (2018) (10)
Genomic Copy Number Variants: Evidence for Association with Antibody Response to Anthrax Vaccine Adsorbed (2013) (10)
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS. (2015) (10)
Evaluation of a web-based fall prevention program among people with multiple sclerosis. (2019) (10)
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America (2021) (10)
The magnetic resonance imaging ‘rule of five’: predicting the occurrence of relapse (2013) (10)
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis (2006) (10)
Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical Trials. (2018) (10)
Adopting an evidence-based lifestyle physical activity program: dissemination study design and methods (2012) (10)
Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE (2018) (10)
Early Cardiac and Cerebral Hemodynamics with Umbilical Cord Milking Compared with Delayed Cord Clamping in Infants Born Preterm. (2020) (9)
Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab. (2014) (9)
Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosis. (2019) (9)
Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies (2022) (9)
Clinical trial design for progressive MS trials (2017) (9)
A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depression (2018) (9)
Effect of physical comorbidities on risk of depression in Multiple Sclerosis (2013) (9)
Premature Infants Receiving Cord Milking or Delayed Cord Clamping: A Randomized Controlled Non‐inferiority Trial: LB 1 (2019) (9)
Prevalence odds ratio versus prevalence ratio: choice comes with consequences. (2017) (9)
Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. (1992) (9)
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (2021) (9)
Prevalence of Sun Protection at Outdoor Recreation and Leisure Venues at Resorts in North America (2017) (9)
Return of hypertension after withdrawal of prolonged antihypertensive therapy, effect of weight loss, sodium reduction, and baseline factors. (1984) (9)
Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity (2010) (9)
Distinct populations of label-retaining cells in the adult kidney are defined temporally and exhibit divergent regional distributions. (2014) (9)
Sample Size in Obesity Trials: Patient Perspective Versus Current Practice (2010) (9)
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint (2010) (9)
Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS. (2019) (8)
Efficacy of a premixed semisynthetic human insulin regimen. (1989) (8)
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials. (2016) (8)
Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis (2019) (8)
Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosis (2018) (8)
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis (2021) (8)
Go Sun Smart (2008) (8)
Rigorous control conditions diminish treatment effects in weight loss-randomized controlled trials (2016) (8)
Slow Wave Sleep and EEG Delta Spectral Power are Associated with Cognitive Function in Parkinson's Disease. (2020) (8)
Epidemiologic Study of Candidates for Coronary Artery Bypass Surgery (1982) (8)
Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972)) (2013) (8)
The CombiRx Trial: A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Participants with Relapsing-Remitting Multiple Sclerosis – Clinical Outcomes (PL02.003) (2012) (8)
Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis? (2021) (8)
The Natural History of Smoking Cessation Among Patients Undergoing Coronary Arteriography (1985) (7)
A Randomized Trial of an Advanced Sun Safety Intervention for Vacationers at 41 North American Resorts (2017) (7)
Statistical cures and other fallacies (2012) (7)
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience (2014) (7)
Ocrelizumab Treatment Effect on Upper Limb Function in PPMS Patients with Disability: Subgroup Results of the ORATORIO Study to Inform the ORATORIO-HAND Study Design (P3.2-091) (2019) (7)
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis (2021) (7)
Estimating power with effect size versus slop differences: Both means and variance matter (2011) (7)
Updated Incidence of Natalizumab-associated Progressive Multifocal Leukoencephalopathy (PML) and Its Relationship with Natalizumab Exposure Over Time (2815) (2020) (7)
Effects of walking exercise training on learning and memory and hippocampal neuroimaging outcomes in MS: A targeted, pilot randomized controlled trial. (2021) (7)
Clinical trials in multiple sclerosis: milestones (2018) (7)
Translation of a Ski School Sun Safety Program to North American Ski and Snowboard Schools (2015) (7)
Bayesian interim analysis in clinical trials. (2008) (7)
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD (2021) (7)
The MS Co-O perative Research (MS-CORE) group: an alternate approach to fostering multicenter studies (2004) (7)
Sustained use of an occupational sun safety program in a recreation industry: follow-up to a randomized trial on dissemination strategies (2015) (7)
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder. (2021) (7)
MRI lesions: a surrogate for relapses in multiple sclerosis? (2013) (7)
Factors associated with excessive sitting time in multiple sclerosis. (2018) (7)
Two-group time-to-event continual reassessment method using likelihood estimation. (2015) (7)
Multiple sclerosis: clinical trial design 2019 (2019) (7)
Interferon-beta for multiple sclerosis: Long-term benefits? (2007) (7)
Interferon‐β for multiple sclerosis: Long‐term benefits? (2007) (7)
Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (2017) (6)
A comparison of clinical outcomes in PPMS in the INFORMS original trial data set (2021) (6)
MHC-dependent desensitization of intrinsic anti-self reactivity (2009) (6)
Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution (2018) (6)
The Sustainability of an Occupational Skin Cancer Prevention Program (2015) (6)
Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease (2017) (6)
Relapses in multiple sclerosis (2009) (6)
CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients (2019) (6)
Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosis (2003) (6)
Using practice effects for targeted trials or sub-group analysis in Alzheimer’s disease: How practice effects predict change over time (2020) (6)
Pseudobulbar affect: Prevalence and association with symptoms in multiple sclerosis (2018) (6)
Functional gastrointestinal disorders negatively affect health-related quality of life in MS. (2019) (6)
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial (2021) (6)
071 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the touch® prescribing program (2018) (6)
The Practical Use of Charts to Estimate Resting Energy Expenditure in Adults (2004) (6)
Erratum to “The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial” [J. Neuroimmunol. 201–202(2008)80–84] (2009) (6)
A retrospective review of lithium usage in veterans with multiple sclerosis. (2013) (6)
Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy (2021) (6)
A two-compartment regression model applied to compliance in a hypertension treatment program. (1980) (6)
An assessment of the Environmental Protection Agency's asbestos hazard evaluation algorithm. (1983) (6)
An Intervention for Changing Sedentary Behavior Among African Americans With Multiple Sclerosis: Protocol (2019) (6)
Distributed data analysis in a multicenter study: the CARDIA Study. (1992) (5)
Natural History of MS Symptoms: Perceived Disease Impact across Disease Span in Nine Neurologic Domains among Enrollees in North American Research Committee on Multiple Sclerosis (NARCOMS) Registry (P07.073) (2012) (5)
Neurofibromatosis Clinical Trial Consortium (2018) (5)
The emerging postural instability phenotype in idiopathic Parkinson disease (2022) (5)
Pedestrian safety in patients with Parkinson's disease: A case‐control study (2017) (5)
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout (2019) (5)
Increasing utilization of a rural cervical cancer detection program. (1981) (5)
The Potential for EBV Vaccines to Prevent Multiple Sclerosis (2022) (5)
Results of the Phase 3 SPI2 Study of MD1003 (high dose Pharmaceutical grade Biotin) in Progressive MS (680) (2020) (5)
Disease-modifying therapy prescription patterns in people with multiple sclerosis by age (2021) (5)
Temporal characteristics of cold pain perception (2010) (5)
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum (2021) (5)
Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis. (2020) (5)
Multiple sclerosis drugs: how much bang for the buck? (2015) (5)
Feasibility of “Sit Less, Move More”: An intervention for reducing sedentary behavior Among African Americans with MS (2020) (5)
PATIENT SAFETYA COMPARISON OF OPEN AND CLOSED ANESTHESIA CIRCUITS (1987) (5)
Uptake and Attitudes About Immunizations in People With Multiple Sclerosis (2021) (5)
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study (2021) (5)
Elevated levels of midtrimester maternal serum‐fetoprotein are associated with preterm delivery but not with fetal growth retardation (1993) (5)
A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adult Subjects with Neuromyelitis Optica Spectrum Disorders–Top line efficacy and safety results (Plen02.001) (2019) (5)
Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing‐remitting multiple sclerosis (2021) (5)
Randomized Controlled Trial of CI Therapy for Progressive MS: Increased Real-World Function and Neuroplasticity on MRI (I7-1.008) (2014) (5)
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances. (2016) (5)
Physical activity and self-reported sleep quality in adults with multiple sclerosis. (2021) (5)
Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1 (2020) (5)
Bayesian sample size determination under hypothesis tests. (2011) (5)
Clinical trials in multiple sclerosis: potential future trial designs (2019) (5)
Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosis. (2020) (4)
National Variation of Technical Factors in Computed Tomography of the Head (2013) (4)
Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis (2021) (4)
Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment (2015) (4)
EFFECT size or statistical significance, where to put your money. (2019) (4)
Hypertension detection and follow-up program. Baseline physical examination characteristics of the hypertensive participants. (1983) (4)
Randomized Trial of Thymectomy in Myasthenia Gravis. (2016) (4)
Association of factor B with ischemic heart disease (IHD). (1984) (4)
Statistical Considerations for an Adaptive Design for a Serious Rare Disease (2016) (4)
Bifactor structure of clinical disability in relapsing multiple sclerosis. (2014) (4)
Condylomata Acuminata in IDDM (1988) (4)
Comparison of Hypertension Prevalence and Control in 5,237 Rural and Urban Alabama Residents (1987) (4)
ETHNICITY AS A RISK FACTOR FOR CONTACT LENS RELATED BIOMICRO-SCOPIC SIGNS.: 1:20 pm (CL-391) (1995) (4)
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout. (2020) (4)
Relapse Is Associated with Residual Deficits in Relapsing-Remitting Multiple Sclerosis: Analysis of FREEDOMS Data (P07.118) (2013) (4)
Temporal dynamics of the multi-omic response to endurance exercise training across tissues (2022) (4)
Training and certification of blood pressure observers in a clinical trial (1981) (4)
A study of the cost of tuberculosis contact investigation related to non-tuberculous mycobacterial isolation in Jefferson County, Alabama. (1987) (4)
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis (2016) (4)
A longitudinal study of symptom botheration in Multiple Sclerosis. (2020) (4)
Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissions (2022) (4)
Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over time (2019) (4)
Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QD. (2020) (4)
Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis (2019) (4)
SARS-CoV-2 infection increases risk of acute kidney injury in a bimodal age distribution (2022) (4)
A Framework of Care in Multiple Sclerosis, Part 1 (2016) (4)
Employment in Refractory Myasthenia Gravis: An Mgfa Registry Analysis. (2019) (4)
Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note (2017) (4)
Mortality surveillance in collaborative trials. (1980) (4)
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials (2021) (4)
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning (2021) (4)
A novel Mendelian randomization method with binary risk factor and outcome (2021) (4)
MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis (2021) (4)
EDSS Changes in CombiRx: Blinded, 7-Year Extension Results for Progression and Improvement (P04.121) (2013) (4)
Dog Biscuits: An Aid in Canine Tartar Control (1991) (4)
Publication outcomes of abstracts from the American Society of Hematology Annual Meeting (2017) (4)
Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis Complex. (2020) (4)
Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era (2018) (4)
Does natalizumab therapy benefit patients with multiple sclerosis? (2014) (3)
Proof of concept studies for tissue-protective agents in multiple sclerosis (2009) (3)
Acute flaccid myelitis: long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitis (2021) (3)
Long-term registries: Answering tough questions with big data? (2016) (3)
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions. (2022) (3)
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a (2020) (3)
3: Azithromycin-based extended spectrum antibiotic prophylaxis for non-elective cesarean delivery: a pragmatic multicenter placebo-controlled double-blind rct (2016) (3)
Intensive and App-Delivered Occupational Therapy to Improve Upper Extremity Function in Early Diffuse Cutaneous Systemic Sclerosis: A Pilot Two-Arm Trial. (2021) (3)
New applications for independent activities of daily living in measuring disability in multiple sclerosis (2020) (3)
The Importance and Opportunity for Healthy Aging Through Lifestyle, Behavior Medicine Among Older Adults With Multiple Sclerosis: the Case Based on Physical Activity (2021) (3)
Clinical trials in multiple sclerosis. (2014) (3)
Design and baseline data of a randomized trial comparing two methods for scaling-up an occupational sun protection intervention (2020) (3)
Cohort analysis of secular change in mortality in patients with cad undergoing surgical intervention (1981) (3)
The self-management behaviors of soft contact lens wearers: The effect of lens modality (1995) (3)
Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Longitudinal, Magnetic Resonance Imaging, Blinded Pilot Study (2010) (3)
Effect size - one size doesn't fit all. (2020) (3)
Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseases. (2022) (3)
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis. (2015) (3)
Quality of Care for Veterans With In-Hospital Stroke. (2019) (3)
Exercise training in multiple sclerosis (2022) (3)
Relapse Activity in the CombiRx Trial: Blinded, 7-Year Extension Results (S01.002) (2013) (3)
Effects of very low birth weights on fetal and neonatal mortality rates in Alabama. (1989) (3)
Does effective antihypertensive therapy partially "cure" hypertension? (1985) (3)
Methodological issues in using time series designs and analysis: evaluating the behavioral impact of health communication programs. (1982) (3)
Benthic foraminifera and ostracoda from Virginia continental shelf (1998) (3)
Featured Articles Requiring an amyloid-b 1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials (2010) (3)
Body mass index correlates with multiple sclerosis disease and symptom severity in women, but not in men (2017) (3)
The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial dataset (2022) (3)
The Virtual Short Physical Performance Battery: Psychometric Properties and Validation in Older Adults With Multiple Sclerosis (2019) (3)
Video Telehealth Pulmonary Rehabilitation for COPD Is Associated with Clinical Improvement Similar to Center Based Pulmonary Rehabilitation (2021) (3)
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient. (2022) (3)
Longitudinal Analysis of Disease Burden in Refractory and Nonrefractory Generalized Myasthenia Gravis in the United States (2020) (3)
COVID‐19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings (2022) (3)
NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDY (2018) (3)
The Go Sun Smart Campaign: Achieving Individual and Organizational Change for Occupational Sun Protection (2013) (3)
CLINICAL PRESENTATION AND SYMPTOMATOLOGY OF PATIENTS WITH FOCAL CORNEAL INFILTRATES WITH OVERLYING FLUORESCEIN STAINING: 1:40 pm (CL-389) (1995) (3)
Evidence of treatment benefit: is seeing believing or obfuscation by statistics? (2009) (3)
The return of the house call? (3)
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience (2021) (2)
Demographic, clinical, and symptomatic correlates of subjective sleep quality in adults with multiple sclerosis. (2021) (2)
Arteriovenous Fistula Nonmaturation: What’s the Immune System Got to Do with It? (2021) (2)
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. (2020) (2)
Maternal Serum Alpha2-Macroglobulin and Fetal Growth Retardation (1991) (2)
Physical and Mental Health–Related Quality of Life Trajectories Among People With Multiple Sclerosis (2022) (2)
Natalizumab extended interval dosing (EID) is associated with a reduced risk of progressive multifocal leukoencephalopathy (PML) than every-4-week (Q4W) dosing: Updated analysis of the TOUCH® Prescribing Program database (1988) (2020) (2)
Therapeutic considerations: Rating scales (2001) (2)
Sustained High Level of Healthcare Worker Adherence With Hand Hygiene Practice Recommendations Using the Patient-as-Observer Approach in the Ambulatory Setting (2016) (2)
MRI Outcomes in CombiRx: Blinded, 7-Year Extension Results (S01.003) (2013) (2)
Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis (2022) (2)
Disparities in Telehealth Care in Multiple Sclerosis (2022) (2)
Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States (2020) (2)
Preliminary report of a multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study. (2018) (2)
CSF plasmablasts differentiate MS from other neurologic disorders. (2020) (2)
Fluorescence microscopy of DES-induced morphologic transformation in unfixed, cultured cells. (1989) (2)
Indirect Comparisons of Oral Fingolimod Versus Natalizumab on Measures of Disease Freedom Based on Results from FREEDOMS and AFFIRM (P01.209) (2013) (2)
Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program (2019) (2)
Effect of Switching from Intramuscular Interferon b-1a to Fingolimod on Time to Relapse in Patients with Relapsing-Remitting Multiple Sclerosis Enrolled in a 1-Year Extension of TRANSFORMS (P07.107) (2013) (2)
Factors Associated with Early Childhood Caries Incidence among African-American Children in Alabama (2016) (2)
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials (2022) (2)
Diet Quality Assessment in Wheelchair Users with Multiple Sclerosis (2021) (2)
Predictive value of baseline and short-term outcomes on mortality in multiple sclerosis: Data from the interferon beta-1b 21-year long-term follow-up study (2011) (2)
The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis (2022) (2)
Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative. (2020) (2)
LIMITATIONS OF THE FDA-APPROVED ‘AD CLINICAL TRIAL SIMULATION TOOL’ (2016) (2)
Quality of life assessment in a low vision population (1997) (2)
Impact of Maternal Group B Streptococcal Screening on Pediatric Management in Full-Term Newborns (1997) (2)
The Problem of Spurious Correlations Between Pairs of Brain Metabolite Values Measured in the Same Voxel With Magnetic Resonance Spectroscopy—Reply (2014) (2)
Fingolimod Effects on PASAT Score and Baseline Determinants of PASAT in a Large Cohort of RRMS Patients (P2.150) (2016) (2)
Continued benefits of a technical assistance web site to local tobacco control coalitions during a state budget shortfall. (2011) (2)
A new device for collecting cord blood. (1995) (2)
Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS (2021) (2)
Neonatal mortality in infants born weighing 501 to 1000 grams (1985) (2)
A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod (2021) (2)
Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate. (2021) (2)
Does Change in Acetylcholine Receptor Antibody (AChR-Ab) Level Predict or Correlate with Clinical Change in Myasthenia Gravis (MG)? (S45.006) (2013) (2)
Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping With Death or Severe Intraventricular Hemorrhage Among Preterm Infants (2020) (2)
The best and worst of times in therapy development for myasthenia gravis (2022) (2)
Cause of death in patients with multiple sclerosis: The 21-year long-term follow-up study (2011) (2)
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree (2016) (2)
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease (2022) (2)
A Multi-Center Controlled Study of the Acute and Chronic Effects of Cooling Therapy for MS (2000) (1)
Comparative Feasibility Study in GOUt, CHerry Extract Versus Diet Modification (Mini-GOUCH) (2020) (1)
UAB-UCSD O'Brien Center for Acute Kidney Injury Research. (2021) (1)
Clinical Outcomes and Cause of Death for Interferon Beta-1b Versus Placebo, 21 Years Following Randomization (P04.129) (2012) (1)
A Genetic Model To Predict Response to Glatiramer Acetate Developed from a Genome Wide Association Study (GWAS) (IN3-2.003) (2012) (1)
The King-Devick (K-D) Test of Rapid Eye Movements: A Bedside Correlate of Disability and Quality of Life in Multiple Sclerosis (IN4-2.004) (2013) (1)
Mortality in Multiple Sclerosis in the United States (MIMS-US): A Retrospective, Cohort Study of Survival and Mortality Trends (P06.195) (2012) (1)
Effect of Pharmaceutical Formulation of Purified Cannabidiol (CBD) on Seizure Frequency and Severity is Independent of Drug-Drug Interactions with other Anti-Epileptic Drugs (AEDs) (P4.271) (2018) (1)
Inverse dependence between patient population and correlation of composite MRI scores with EDSS in Multiple Sclerosis (2008) (1)
An enrichment strategy for clinical trials in SPMS (2021) (1)
Effect of Fingolimod on Confirmed Improvement in Physical Disability: Post-Hoc Analyses of FREEDOMS I and TRANSFORMS (P07.108) (2013) (1)
Reply: To PMID 22581550. (2013) (1)
Reduced risk of progressive multifocal leukoencephalopathy (PML) associated with natalizumab extended interval dosing (EID): updated analysis of the TOUCH® Prescribing Program database (S26.006) (2019) (1)
A CASE CONTROL STUDY OF RISK FACTORS IN DEVELOPMENT OF FOCAL CORNEAL INFILTRATES WITH OVERLYING FLUORESCEIN STAINING.: 2:00 pm (CL-388) (1995) (1)
The Non-Inferiority Complex: What Do Non-Inferiority Trials Tell Us? (2022) (1)
CLINICAL PRESENTATION, PREVALENCE AND RISK FACTORS OF FOCAL INFILTRATES IN GENERAL EYE CARE PRACTICES: 1:40 pm (CL-357) (1994) (1)
Differences in Bladder Care for Veterans with Multiple Sclerosis by Treatment Location (2009) (1)
Requiring a CSF amyloid-β42 biomarker for a prodromal AD research diagnosis does not result in better clinical trials: Simulations from the ADNI database (2010) (1)
Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error? (2016) (1)
RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (2017) (1)
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS (2022) (1)
Intrauterine growth retardation and preterm delivery: Prenatal risk factors in an indigent population (1990) (1)
Evidence-based guideline update: plasmapheresis in neurologic disorders. (2011) (1)
A Genetic Model Predicts the Response to Glatiramer Acetate in Two Different Cohorts (P05.129) (2012) (1)
Optometric care and undetected eye disease: a case of Berkson's bias? (1995) (1)
Analysis of Diagnoses Associated with Multiple Sclerosis-Related In-Hospital Mortality Using the Premier Hospital Database. (2016) (1)
Novel designs for clinical trials in multiple sclerosis: another excursion to Sirenum scopuli? (2008) (1)
ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL (2019) (1)
Rules of Evidence for Clinical Trials (2008) (1)
Mediation of a school based skin cancer prevention program. (2006) (1)
Chronobiology of Hypertension in Sickle Cell Disease (2014) (1)
Patient-Centered Outcomes and Key Study Procedure Finalization in the Pilot Feasibility Gout Randomized Trial (2019) (1)
Psychometric Evaluation of Quality of Life (QoL) and Disease Severity Outcome Measures in Myasthenia Gravis (MG) Using Rasch Analysis (P05.174) (2012) (1)
OR.2. Epitope-Specific Therapy in Rheumatoid Arthritis, Phase 2 Clinical and Immunological Results (2006) (1)
CAUSE OF DEATH IN MULTIPLE SCLEROSIS PATIENTS FROM THE 21-YEAR LONG-TERM FOLLOW-UP STUDY (2011) (1)
Effect of Fingolimod in Patients with No Disability as Measured by EDSS at Baseline: Post-Hoc Analyses of FREEDOMS I and II (P07.124) (2013) (1)
Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial (2019) (1)
Supporting Tobacco Control (2011) (1)
A Bayesian Method of Estimating Kappa Coefficient with Application to a Rheumatoid Arthritis Study (2009) (1)
Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset (2021) (1)
The feasibility of long-term treatment of diabetes with continuous subcutaneous insulin infusion (1993) (1)
The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing–Remitting Multiple sclerosis: A CombiRx Secondary Analysis (2021) (1)
VARIABILITY OF TWO SAMPLING METHODS IN PLAQUE SAMPLES KUEI-LING C. HSU NOEL K CHILDERS, COMMITTEE CHAIR (2008) (1)
Biomarkers and Relapse in CombiRx (P5.221) (2015) (1)
A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis. (2021) (1)
ADVANCING THERAPEUTICS FOR NEUROINFLAMMATION IN ALZHEIMER'S DISEASE: CLINICAL DEVELOPMENT CONSIDERATIONS (2016) (1)
Correction to: "Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective Multicenter Cohort Study of Imaging Selection". (2020) (1)
Poster 230: Hand Function, Mobility, and Employment Status in the NARCOMS Registry (2010) (1)
Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis (2022) (1)
Association of Umbilical Cord Milking Versus Delayed Umbilical Cord Clamping With Death or Severe Intraventricular Hemorrhage Among Preterm Infants (2020) (1)
A-75Financial Decline in Patients with Mild Cognitive Impairment: A Six-year Longitudinal Study (2014) (1)
Marijuana Usage and Disability in MS in the NARCOMS Registry (P1.140) (2015) (1)
MS Diagnostic Criteria: Moving Ahead or Walking in Place? (2021) (1)
The Emerging Gait Dysfunction Phenotype in Idiopathic Parkinson’s Disease (2019) (1)
Amnestic MCI/ prodromal Alzheimer's disease with more severe memory deficit is indistinguishable from diagnosed Alzheimer disease: Implications for the validity of clinical trials and biomarkers (2011) (1)
Clinical Trials in Neurology: Multiple Sclerosis (2012) (1)
Improvements in the Power of Detecting Treatment Effect in a Primary Progressive Multiple Sclerosis (PPMS) Clinical Trial with the Use of Composite Disability Outcome Endpoints (P01.151) (2012) (1)
Repurposing Domperidone in Secondary Progressive MS: A Simon 2-Stage Phase 2 Futility Trial (2021) (1)
If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it? (2021) (1)
Cost-effectiveness analyses: Beauty and the beast? (2013) (1)
White matter tracts that overlap with the thalamus and the putamen are protected against multiple sclerosis pathology. (2021) (1)
Accuracy and Repeatability of Internet-ordered Spectacle Lenses (2021) (1)
Video Telehealth Pulmonary Rehabilitation for COPD is Associated with Clinical Improvement Similar to Center Based Pulmonary Rehabilitation. (2021) (1)
Sources of Cannabis Information and Medical Guidance for Neurologic Use (2022) (1)
Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: A retrospective analysis from the CombiRx trial (2021) (1)
Video Telehealth Pulmonary Rehabilitation Intervention in COPD Reduces 30-Day Readmissions (2019) (1)
Mendelian randomization in the multivariate general linear model framework (2021) (1)
One‐year follow‐up of disease burden and medication changes in patients with myasthenia gravis: From the MG Patient Registry (2022) (1)
POS0135 REDUCING IMMUNOGENICITY OF PEGLOTICASE (RECIPE) WITH CONCOMITANT USE OF MYCOPHENOLATE MOFETIL IN PATIENTS WITH REFRACTORY GOUT: A PHASE II RANDOMIZED CONTROLLED TRIAL (2021) (1)
Impact of the COVID‐19 pandemic on patients with myasthenia gravis: A survey of the Myasthenia Gravis Foundation of America MG patient registry (2022) (1)
Abstract TMP16: IV tPA Does Not Delay Endovascular Thrombectomy and is Associated With Improved Clinical Outcomes (2019) (0)
Association, Cause, and Correlation (2014) (0)
3527 Intensity normalization for improved MR images analysis (2013) (0)
Diagnoses, Symptoms, andAttribution ofSymptoms among Black andWhite Inpatients Admitted forCoronary I:Heart Disease (1993) (0)
17Monitoring and Research Studies (2002) (0)
Rett syndrome: Novel correlations linking >96% genotype, disease severity, and seizures (2021) (0)
Baseline Characteristics of the CHORDS Study Population: A Phase III Trial to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With RRMS Who Had Disease Activity With Prior Disease-Modifying Therapies (P6.370) (2018) (0)
SEX IS NOT AN IMPORTANT PREDICTOR OF CHANGE IN ALZHEIMER’S CLINICAL TRIAL OUTCOMES (2019) (0)
DIFFERENCES IN ALZHEIMER DISEASE CLINICAL TRIALS OUTCOMES BASED ON AGE OF PATIENTS (2014) (0)
Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis (2022) (0)
Imposter clinical trials or answering questions with observational data. (2023) (0)
Depression and MRI Metrics in the CombiRx Trial (P5.198) (2015) (0)
Multiple Sclerosis Diagnostic Criteria (2022) (0)
Can We Improve Resting Energy Expenditure (REE) Predictions Using a Pooled Data Set and New Formulas (2005) (0)
Amyotrophic Lateral Sclerosis in a Large African American Population, Does It Differ from Caucasians? (P01.098) (2012) (0)
The impact of relapse definition and measures of durability on MS clinical trial outcomes (2023) (0)
CORRECTION (2008) (0)
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial (2021) (0)
Effect of APOE genotype on clinical trial outcomes (2013) (0)
Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer’s Disease (2022) (0)
Abstract PR008: Identification and characterization of the cancer permissive environment in companion dogs (2023) (0)
Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (2017) (0)
Myasthenia Gravis Patient Registry: Knowledge Gap in Understanding Disease Diagnosis and Treatment (P1.134) (2016) (0)
Dissemination of Go Sun Smart in Outdoor Recreation: A Theory-Based Health Communication Program (2011) (0)
FP39-WE-01 Long-term follow-up 20 years after the pivotal interferon beta-1b multiple sclerosis trial (2009) (0)
Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study. (2023) (0)
Author response: High hypothetical interest in physician-assisted death in multiple sclerosis (2017) (0)
Functional Gastrointestinal Disorders Negatively Affect Health-Related Quality of Life in Multiple Sclerosis (2019) (0)
COVID-19 ASSOCIATED RISKS AND EFFECTS IN MYASTHENIA GRAVIS (CARE-MG): AN INTERNATIONAL PHYSICIAN-REPORTED REGISTRY (2020) (0)
Prednisone Side Effects are Common and Associated with Unwillingness to Accept a Dose Increase: Survey Result from MGFA Registry (P6.443) (2018) (0)
2 Optimizing patient selection for endovascular treatment in acute ischemic stroke (SELECT): a prospective non-randomized multicenter cohort study of imaging selection (2018) (0)
Improved Estimation Of Treatment Effects: Analysis Of Time To Recurrent Relapse With Fingolimod Or Intramuscular Interferon Beta-1a Treatment Using The Proportional Means Model (P7.220) (2014) (0)
Abstract WP75: Ischemic Core Volume Modifies the Association Between ASPECT Score and Clinical Outcome (2019) (0)
Functional System Changes Associated with Relapse: The CombiRx Experience (P3.285) (2015) (0)
Challenging Assumptions About African American Participation in Alzheimer’s Trials (2018) (0)
Effects of exercise on sleep spindles in Parkinson's disease (2022) (0)
Data Discrepancies and Audit Effects in the Umbilical Artery Catheter Trial (1994) (0)
Anticholinergic burden among participants in Alzheimer’s clinical trials (2020) (0)
CTNI-10. MAINTENANCE CHEMOTHERAPY USING BEVACIZUMAB FOR NEUROFIBROMATOSIS 2 PATIENTS WITH HEARING LOSS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (NF104) (2020) (0)
COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes (2022) (0)
Clinical Efficacy of Laquinimod 0.6 mg Once Daily in the Treatment of Worsening Relapsing-Remitting Multiple Sclerosis (Baseline EDSS >3) (P3.051) (2016) (0)
Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants. (1983) (0)
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials. (2023) (0)
Factors That Predict Adoption and Implementation of an Evidence-based Physical Activity Program (2011) (0)
Development and validation of a VA risk function to predict mortality (1981) (0)
BST 2009-001 Modelling Lesion Counts Data in Multiple Sclerosis When Patients have been Selected for Baseline Activity Charity (2009) (0)
EFFECT OF WEIGHT LOSS ON THE RETURN OF HYPERTENSION AFTER WITHDRAWAL OF PROLONGED ANTIHYPERTENSIVE THERAPY (1984) (0)
PND93 - THE IMPACT OF MYASTHENIA GRAVIS (MG) ON HEALTHCARE RESOURCE UTILIZATION: EMPIRICAL EVIDENCE FROM A US REGISTRY SAMPLE (2018) (0)
REAL-TIME QUANTITATIVE PCR FOR EVALUATION OF MUTANS STREPTOCOCCI AND DENTAL CARIES by CHANIKA MANMONTRI (0)
Longitudinal Assessment of Multiple Sclerosis Patients and Reimbursement Issues (2005) (0)
Multiple Sclerosis Therapeutics: Measures of neurological impairment and disability in multiple sclerosis (2011) (0)
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis (2022) (0)
Measuring Enduring Worsening Of Multiple Sclerosis In The CombiRx Study (S34.007) (2014) (0)
Abstract 19094: Use of ACE Inhibitors or Angiotensin Receptor Blockers is Associated With a Significantly Lower Risk of 30-day All-cause and Heart Failure Readmissions and All-cause Mortality in Older Medicare Beneficiaries Hospitalized for Heart Failure Developing Acute Kidney Injury (2015) (0)
Abstract WMP9: Does Repeat Images Improve Patient Selection and Clinical Outcomes in Patients Transferred for Endovascular Thrombectomy? (2019) (0)
Personalizing treatment effect based on patient's baseline profile: a statistical modelling approach applied to randomized clinical trial and observational study data (2019) (0)
BASELINE COGNITIVE SEVERITY DOES NOT PREDICT RATE OF CHANGE IN THE ADAS-COG CLINICAL TRIALS (2014) (0)
Comparison of the Effectiveness of Nasal Packing Devices for Emergency Department Treatment of Epistaxis (2005) (0)
Mortality and survival trends in US multiple sclerosis patients (2011) (0)
Response to Pharmaceutical Formulation of Purified Cannabidiol (CBD) in Pediatric and Adult Patients with Treatment-Refractory Epilepsy (P1.030) (2018) (0)
Re: Practice parameters in myasthenia gravis (2011) (0)
The Clinical Impact of Daptomycin Non-susceptible Enterococcus Bacteremia in Hematologic Malignancy (2017) (0)
Early first‐line treatment response and subsequent disability worsening in relapsing–remitting multiple sclerosis (2021) (0)
THE IMPACT OF A CLINICAL TRIAL ON PERFORMANCE BY ANESTHESIOLOGISTS: ASSESSMENT OF CLINICAL COMPETENCE (1985) (0)
Subcategory Analysis of Causes of Death in Patients with Multiple Sclerosis from a Large US Insurance Database (S30.007) (2013) (0)
Women and Neurological Disability: End-of-Life Care and Mortality in Women with MS (2017) (0)
T55. POLYGENICITY OF COMORBID DEPRESSION IN MULTIPLE SCLEROSIS (2022) (0)
How does differential effect of treatment in ApoE-ɛ4+ carriers change clinical trial design in Alzheimer’s disease? (2015) (0)
Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis (2021) (0)
Clinical outcomes assessment in multiple sclerosis: Part II (1996) (0)
sclerosis trials The Multiple Sclerosis Functional Composite : a new clinical outcome measure for multiple (2006) (0)
Abstract 164: Early Infarct Growth Correlates With Both Collateral Status and Clinical Outcomes After Thrombecomy (2019) (0)
EXERCISE IMPROVES SIT-TO-STAND FUNCTION IN PEOPLE WITH MULTIPLE SCLEROSIS (2012) (0)
An Intervention for Changing Sedentary Behavior Among African Americans With Multiple Sclerosis: Protocol (Preprint) (2018) (0)
Comorbidity burden in Alzheimer’s disease clinical trials (2020) (0)
Sales to apparently alcohol-intoxicated customers and online responsible vendor training in recreational cannabis stores in a randomized trial. (2020) (0)
In reply. (2014) (0)
Outcomes in Clinical Trials (2020) (0)
Characteristics of Switchers to Newer Therapies in the NARCOMS Registry (P3.282) (2015) (0)
Randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis project: Secondary, patient-reported outcomes. (2022) (0)
Issue Information ‐ Table of Content (2022) (0)
LENS CARE SYSTEMS, COMPLIANCE, AND CONTACT LENS-RELATED SIGNS AND SYMPTOMS: Poster # 20 (CL-360) (1994) (0)
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) (2023) (0)
Randomized Trial Testing an Online Responsible Vendor Training in Recreational Marijuana Stores in the United States. (2021) (0)
Abstract 4: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core Lesions on Either Simple CT or Perfusion Images (2019) (0)
Does Plasma Exchange Help Improve Physical Function in Children with Transverse Myelitis? -- The CAPTURE Study (2021) (0)
Acute Kidney Injury ( AKI ) and Dialysis Predicts Are Independent Predictors of Mortality in Neonatal Non-Cardiac Patients Receiving ExtraCorporeal Life Support (2009) (0)
Thymectomy in Non-thymomatous Myasthenia Gravis: Results from MGTX, a Randomized, Controlled Trial (S28.003) (2016) (0)
RACIAL AND ETHNIC DIFFERENCES IN CONCOMITANT USE OF CHOLINESTERASE INHIBITORS AND MEMANTINE IN ALZHEIMER’S CLINICAL TRIALS (2018) (0)
Review of OCS part of this manuscript (2019) (0)
Myasthenia Gravis Activities of Daily Living (MG-ADL) Response to Eculizumab Treatment in Patients from the Generalized Myasthenia Gravis Registry (P1-5.020) (2023) (0)
Reply (2013) (0)
NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDY (2020) (0)
Randomized Trial Testing the Efficacy of Sun Safety Programs on CD-ROM for Elementary School Children (2006) (0)
Regional Gray Matter Atrophy in Multiple Sclerosis using Tensor Based Morphometry : A Multi-Center Study (2012) (0)
PROGRESSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER’S DISEASE IN CANCER SURVIVORS (2019) (0)
Estimation of Brain Volume Loss with Multiple Imputation of Missing Values in the Placebo-Controlled FREEDOMS Trials of Fingolimod (P3.056) (2016) (0)
Nutrition Monitoring and Research Studies Observational Studies (2013) (0)
Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia (2022) (0)
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis (2016) (0)
MGBase: The launch of an international electronic database for patients with Myasthenia Gravis (P7-8.014) (2023) (0)
THE EFFECT OF THE DEGREE OF REFRACTIVE ERROR ON HYDROGEL CONTACT LENS WEAR: 2:40 pm (CL-326) (1994) (0)
Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis. (2023) (0)
Defining Responders and Non-responders (2007) (0)
Diet, Physical Activity, and Stress Among Wheelchair Users with Multiple Sclerosis: Examining Behavioral Risk Factors (2022) (0)
Abstract 19999: A Drop in Admission Serum Creatinine is Prognostically Similar to a Rise in Admission Serum Creatinine in Hospitalized Medicare Beneficiaries with Heart Failure: Impact on 30-Day All-Cause Readmission (2014) (0)
Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple Sclerosis (2022) (0)
The emerging postural instability phenotype in idiopathic Parkinson disease (2022) (0)
Clinical trials: To catch a crook, you might try statistics (2017) (0)
Got milk? (2011) (0)
Abstract W P270: Quality of In-Hospital Stroke Care in Veterans Affairs Hospitals (2015) (0)
Advocating for in-center hemodialysis patients via anonymous survey (2022) (0)
Highlights of this Issue (2004) (0)
Natalizumab Extended Interval Dosing (EID) is Associated with a Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) Compared with Every-4-Week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database (P14-3.011) (2023) (0)
Perceptions of physical activity guidelines among wheelchair users with multiple sclerosis (2022) (0)
The nine hole peg test as an outcome measure in progressive MS trials. (2022) (0)
O1-09-02 TWO-PERIOD LINEAR MIXED EFFECTS PRIMARYANALYSIS MODEL FOR CLINICALTRIALS WITH RUN-IN DATA FOR ALZHEIMER DISEASE (2019) (0)
Cannabis Use for Symptom Management Among People with Multiple Sclerosis (PwMS): A 2020 NARCOMS Survey (2021) (0)
Quasi-experimental designs for evaluating cancer control programs in rural settings. (1983) (0)
Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder (2019) (0)
Tracking symptom impact in MS patients: longitudinal study of symptoMScreen scores in patients attending two large tertiary MS centers (2018) (0)
Characteristics of Radiologists (2004) (0)
Sustained Impact of an Occupational Skin Cancer Health Communication Campaign on Outdoor Workers (2004-2012) (2015) (0)
Abstract 671: Development of an exosomal biomarker signature to detect minimal residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning (2021) (0)
Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy (2022) (0)
Quality of In-Hospital Stroke Care in Veterans Affairs Hospitals (P5.146) (2015) (0)
Title: Factors Associated with Early Childhood Caries Incidence among African-American Children in Alabama Running head: Risk Factors for Early Childhood Caries (2014) (0)
Assessment of Caregiver Inventory for Rett Syndrome (2017) (0)
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial (2022) (0)
Relationship between Symptom Worsening, Relapse Activity and Disease Progression in Patients with Multiple Sclerosis (P05.094) (2012) (0)
Who Participates in MS Clinical Trials? The NARCOMS Experience (P3.044) (2016) (0)
TBM Adopting an evidence-based lifestyle physical activity program: dissemination study design and methods (2012) (0)
The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study (2022) (0)
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial (2022) (0)
Reply (2011) (0)
Sa.66Kinetics of Immune Tolerization in a Clinical Trial on Epitope-specific Therapy in Rheumatoid Arthritis (RA) (2007) (0)
Abstract 111: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core and Early Presentation (2019) (0)
Fatigue and Other Patient-Reported Outcomes in Patients With RRMS who Switched to Ocrelizumab: 4-Year Data From CASTING-LIBERTO (P6-3.010) (2023) (0)
Responsiveness and predictive values in PPMS (2008) (0)
Improvement in Cognitive Processing Speed With Ofatumumab in Patients With Relapsing Multiple Sclerosis (P6-3.005) (2023) (0)
Acute Kidney Injury among Liver Transplant Listed Patients Negatively Impacts Wait List Mortality and Predicts Second Episode of Acute Kidney Injury (2016) (0)
Comparative utility of different progression metrics in PPMS: re-analysis of the PROMiSe clinical trial dataset (P7.237) (2015) (0)
CONCOMITANT USE OF CHOLINESTERASE INHIBITORS OR MEMANTINE IS ASSOCIATED WITH COGNITIVE DECLINE IN ALZHEIMER’S CLINICAL TRIALS (2017) (0)
Diet, Physical Activity, and Stress Among Wheelchair Users with Multiple Sclerosis: Examining Individual and Co-Occurring Behavioral Risk Factors. (2023) (0)
Multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: an NF Clinical Trials Consortium study (S23.004) (2018) (0)
Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset. (2023) (0)
Leveraging COViMS Registry to Understand the Impact of COVID-19 on Multiple Sclerosis (2020) (0)
521 Prevalence and Impact of Restless Legs in Patients with Myasthenia Gravis (2021) (0)
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial (2023) (0)
Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis (2022) (0)
NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (2018) (0)
THE USE OF META-DATABASE DATA FOR QUALITY CONTROL IN CLINICAL TRIALS: AN EXAMPLE USING THE MMSE (2014) (0)
Abstract 1747: Oncolytic Vesicular Stomatitis Virus expressing a species relevant interferon-beta is safe and provides a survival benefit when added as neoadjuvant to the standard of care for dogs with naturally occurring bone cancer (2021) (0)
Quantitative Sleep Electroencephalogram in Parkinson's Disease: A Case-Control Study. (2023) (0)
High Frequency and Adverse Impact of Vertigo and Dizziness in Multiple Sclerosis (P07.075) (2012) (0)
5th Conference Clinical Trials on Alzheimer’s Disease (2012) (0)
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients With Parkinson's Disease and a GBA Mutation: Results From Part 1 of the Randomised, Double-Blinded, Placebo-Controlled MOVES-PD Trial (2021) (0)
Baseline cerebellar volume as short-term predictor of clinical disability in Multiple Sclerosis: MRI Findings from the CombiRx trial (S6.005) (2018) (0)
Differential mRNA expression in ectopic germinal centers of myasthenia gravis thymus (2017) (0)
Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease: Phase 2 proof‐of‐concept clinical trial using hippocampal volume as a surrogate endpoint (2022) (0)
199 Changes in natalizumab exposure and PML incidence over time (2019) (0)
The sequential natalizumab – alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial – Part I: Rationale and objectives (2022) (0)
136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MS (2022) (0)
Abnormal thalamic functional connectivity correlates with cardiorespiratory fitness and physical activity in progressive multiple sclerosis. (2023) (0)
Severity and worsening of fatigue among individuals with multiple sclerosis (2023) (0)
Primary results of a phase-III, randomized controlled trial of the Behavioral Intervention for increasing Physical Activity in Multiple Sclerosis project (2023) (0)
Measuring up rates for adverse health behaviors in multiple sclerosis: the need for action (2009) (0)
Do physical activity, cardiorespiratory fitness, and subcortical brain structures explain reduced walking performance in older adults with multiple sclerosis? (2022) (0)
Proportion of in-hospital deaths in multiple sclerosis patients related to septicaemia and upper respiratory infection exceeds that in non-multiple sclerosis patients (2011) (0)
Prognostic C haracteristics o f B reast C ancer A mong Postmenopausal H ormone U sers i n a S creened P opulation (2003) (0)
Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple Sclerosis (2022) (0)
Effect of Fingolimod 0.5 mg/day vs Placebo on Two Newly Developed Expanded Disability Status Scale (EDSS) Subscales for Patients with Relapsing-Remitting MS: EDSS Factor Analysis (P6.354) (2018) (0)
Novel, easy-to-use prediction tool accurately estimates probability of "aggressive MS" at 2-year follow up (P3.214) (2015) (0)
Clinical Trial Design for Myasthenia Gravis (2018) (0)
Abstract 327: The Choice of Diuretic is Important in the Treatment of Resistant Hypertension (2014) (0)
SELF-MANAGEMENT AMONG CONTACT LENS WEARERS: DIFFERENCES BETWEEN DISPOSABLE AND CONVENTIONAL LENS WEARERS: Poster # 17 (CL-331) (1994) (0)
Comparing Disability of Multiple Sclerosis Cohort in a Tertiary Clinic and Volunteer North American Research Committee on Multiple Sclerosis Registry Using Patient-Derived Multiple Sclerosis Severity Score (P3.145) (2014) (0)
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study Authors (2021) (0)
Attitudes of people with multiple sclerosis toward brain donation (2023) (0)
Response to the Letter ‘Efficiency loss due to varying cluster sizes in cluster randomized trials and how to compensate for it: comment on You et al. (2011)’ by van Breukelen and Candel (2012) (0)
Cost-Effectiveness of Prevention, Intervention, and Therapeutic Strategies in Coronary Artery Disease (1988) (0)
Reply to: Exercise for “Sleep Rehabilitation” in Parkinson's Disease (2020) (0)
TITLE: Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex RUNNING TITLE: Autism in Tuberous Sclerosis Complex AUTHORS (2017) (0)
To treat or not to treat, that really is not the question. (2015) (0)
Oncolytic vesicular stomatitis virus is safe and provides a survival benefit for dogs with naturally occurring osteosarcoma (2023) (0)
Beauty and the beast? (0)
Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment (2013) (0)
Micro-RNA and mRNA Profiles Associated with Ectopic Germinal Center Formation in Thymus Samples of Patients with Autoimmune Myas (2016) (0)
Predicting Confirmed Disability Progression In MS: Importance Of Early On-Treatment MRI Changes On Modeling The CombiRx Trial Database (P3.157) (2014) (0)
292 CONSTRAINT-INDUCED MOVEMENT THERAPY FOR IMPAIRED GAIT IN PROGRESSIVE MS: 1-YEAR FOLLOW-UP (2010) (0)
Prevention Program for Adolescents Randomized Trials on Consider This, a Tailored, Internet-Delivered Smoking (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gary R. Cutter?

Gary R. Cutter is affiliated with the following schools:

Gary R. Cutter's Academic­Influence.com Rankings

Gary R. Cutter's Degrees

Similar Degrees You Can Earn

Why Is Gary R. Cutter Influential?

Gary R. Cutter's Published Works

Published Works

What Schools Are Affiliated With Gary R. Cutter?

Gary R. Cutter's AcademicInfluence.com Rankings